Using plasma samples, patients with known tumour mutations revealed increased H3K36me3 cfChIP enrichment for mutated relative to WT alleles for seven of nine genes presented with mutations, including the tumour supressor gene, TP53, and the oncogene, EGFR. This evidence concerns the gene TP53 and neoplasm.